 |
Development Pipeline
 |
 |
 |
Description:
FG-5016, FibroGen's recombinant human collagen (type III) product, is a highly pure
biomaterial for use in a variety of pharmaceutical and medical device applications.
Status: FibroGen has successfully completed a safety study of FG-5016 in normal volunteers. Data from this
study will be included in a Master File for use by FibroGen's customers.
|
|
Key:
MAb: monoclonal antibody
HIF: hypoxia-inducible factor
CKD: chronic kidney disease
CIA: chemotherapy-induced anemia
rhCIII: recombinant human collagen type III
rhGelatin: recombinant human gelatin
* 2nd generation compounds (undisclosed) in parallel development
|
|
